According to the results of this study, AME has beneficial effects on protecting against diabetes-related aberrant peripheral energy metabolism through activation of the PGC1α/SIRT1-dependent mechanism by FGF21. The gene discussed is PPARGC1A; the disease is diabetes mellitus.